Applied Pharmaceutical Analysis 2018

Save the Date for the 14th Annual APA Meeting!
October 1-3, 2018

Short Courses September 30th

Sheraton Boston Hotel 
39 Dalton Street 
Boston, MA 02199

 

APA 2018 Plenary Speakers

donna dambach     

Donna Dambach, VMD, PhD, Senior Director, Head of Toxicology, Safety Assessment, Genentech

Safety Lead Optimization: What We Have Learned from Kinase Inhibitors

     
    

Binodh DeSilva, PhD, Head of Analytical Strategy & Operations, Product Development, BMS

The Impact of a Reagent Center of Excellence on Bioanalysis, and a Company’s Strategy around Variabilization

     
Richard Smith APA2018     

Richard Smith, PhD, Batelle Fellow and Director of Proteome Research, Pacific Northwest National Laboratory

New Developments in Ion Mobility-Mass Spectrometry Enabling Improved Higher Throughput and More Sensitive Proteomics and Pan-Omics Measurements for Clinical Diagnostics and Personalized Medicine

 

APA 2018 Confirmed Speakers

Joseph Camardo, Senior Vice President Celgene Global Health and Global Medical Affairs, Celbene

Attention to Neglected Tropical Diseases: The Impact of the Pharmaceutical Industry and the Mission of Celgene Global Health

  Joe Cornicelli

Joseph Cornicelli,  Director, In Vivo Cardiovascular and Metabolic Diseases, Integrated Drug Discovery, Charles River Laboratories

Title TBA

         
Bill APA photo

William Gerwick, Distinguished Professor of Oceanography and Pharmaceutical Sciences, Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego

Antiparasitic Drug Discovery from Marine Cyanobacteria

  Jochem Gokemeijer

Jochem Gokemeijer, Associate Director, Bristol-Myers Squibb

Title TBA

         
 Vibha Jawa

Vibha, Jawa, Director Biologics and Vaccine Development, Merck

Title TBA

   Sadik Kassim

Sadik Kassim, Vice President, Process and Analytical Development, Mustang Bio

Title TBA

         
 Jun Qu

Jun Qu, Professor, Department of Pharmaceutical Sciences, SUNY-Buffalo, Chief Scientist in Bioanalysis, New York Center of Excellence in Bioinformatics and Life Sciences

Sensitive and Robust Trapping-Micro-LC-MS for the Quantification of Biomarkers and Antibody Therapeutics

   Jing Tao

Jing-Tao Wu, Vice President DMPK and Investigative Toxicology, Alnylam Pharmaceuticals

Mechanistic ADME of siRNA-GaINAc Conjugates

         
 Arindam Dasgupta

Arindam Dasgupta, Deputy Director, Division of New Drug Bioequivalence, OSIS, OTS, CDER, FDA

Common BA/BE Inspection Observations and their Mitigation Strategies

   Sylvia2  

Sylvia Janetzki, Founder and President, ZellNet Consulting

Monitoring the Function of Single Immune Cells - How to Tackle this Daunting Task and Apply Cutting-Edge Developments for Obtaining Meaningful Data

         
Holly Maw

Holly Maw, Scientist IV, Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals

N-methylation of BI 187004 by thiol-S-methyltransferase

   Jonathan Bauman APA2018  

Johnathan Bauman, Principal Scientist, Pfizer

Accelerating the Delivery of Small Molecule High Resolution Accurate Mass Structure Elucidation Results Through the Use of Thermo Scientific™ Compound Discoverer Software™

         
Ming Yao picture APA2018

Ming Yao, Senior Research Scientist, Bristol-Myers Squibb

Fast and Comprehensive Detection and Characterization of Cyclic Peptide Metabolites using Software-Aided Data Processing Tools

   Xiaomin Liang APA2018  

Xiaomin Liang, Research Scientist, Drug Metabolism, Gilead

Title TBA

 

Other confirmed speakers:

Michael F. Skelly, Ph.D., Lead Pharmacologist, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Study Integrity and Surveillance, U.S. Food and Drug Administration

Christopher Kochansky, Ph.D., Associate Principal Scientist, Merck

Jonathan Bauman, Ph.D., Prinicipal Scientist, Pfizer

Jianwei Shen, Ph.D., Prinicipal Scientist, AbbVie 

Chuck Gu, Ph.D. Prinicipal Scientist, Biotransformation Group Lead, Biogen

Holly Maw,Ph.D., Boehringer Ingelheim

Giovanna Scapin, Ph.D., Prinicipal Scientists, Merck

Guowen Liu, Ph.D., Director of Bioanalyis, Agios

Xiaomin Liang, Ph.D., Research Scientist (DMPK), Gilead Sciences

 

 

Proposed Sessions for APA 2018 Workshops 

Regulated Bioanalysis

Regulatory Session / Guidance

Challenges of Immunotherapy in a Regulated Environment

Bioanalytical Support for Novel Therapies

Miscellaneous Topics in Bioanalysis

New Technologies and Applications

Discovery Bioanalysis and New Technologies

Anti-Drug Antibodies (ADA)

Information Technology - Knowledge Management

New Technologies

Omics

Mechanistic ADME

Unusual Metabolites

Toxicity/Safety

Speciality Molecules: Going Beyond the Rule of 5

Software for Met ID

Combined Mechanistic Adme and Discovery Bioanalysis

Role of DMPK in New Modalities

Exploratory Biomarker Analysis

Beyond ADME and Bioanalysis

NASH

CNS

Global Health

Rare/Neglected Diseases

Novel Drug Delivery Systems

   

 

 Join our Linkedin Group:

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Software

Registration

Click here to register for the APA 2018 conference online.

APA 2018 will take place October 1-3, 2018 at:

Sheraton Boston Hotel

Boston, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy